Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sweeteners under the microscope: do they mess with your blood sugar?

NCT ID NCT07361406

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study looks at how non-nutritive sweeteners (like those in diet drinks) affect blood sugar control, gut bacteria, and hunger hormones in healthy adults aged 45-79. Over 6 weeks, participants will consume sweeteners or a control, and researchers will measure changes using glucose tests and other health markers. The goal is to understand if these sweeteners have hidden effects on metabolism.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 79 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 45-79 years; * BMI of 20-35 kg/m2; * Having veins suitable for placement of a venflon catheter. Exclusion Criteria: * Diseases or prior surgeries affecting the stomach, liver, kidneys or intestines (allowed i.e. appendectomy); * Cardiovascular diseases (e.g. heart failure) or cancer (e.g. non-invasive skin cancer allowed); * Diagnosed with type 1 or type 2 diabetes; * Drug treated thyroid diseases (well substituted hypothyroidism is allowed for inclusion); * HbA1c level \>6.5% (\>48 mmol/mol), as measured during the screening visit; * Anaemia defined as Hb concentrations \<8.5 mmol/L for men and \<7.5 mmol/L for women via finger prick; * Regular use of/receiving medication interfering with research outcomes (as judged by research physician), such as use of glucose lowering drugs, insulin, or use of medication that impacts the gastro-intestinal system; * Use of antibiotics over the last 3 months before study start; * Donated blood within 2 months prior to the screening; * Food allergies, intolerances (including lactose/gluten intolerance) for products used in the study design and/or dietary restrictions interfering with the study (including special diets and eating disorders); * Followed a diet that can interfere with the study outcomes within 1 month prior to the screening (e.g. ketogenic, sugar free, carbohydrate free); * Not willing to eat all products in the study diet, including eggs and dairy. Vegetarian is possible; * Not willing to consume non-nutritive sweeteners; * Not willing to quit the use of supplements that can interfere with the study outcomes (e.g. pre- or probiotics). * Intention to change the intensity of exercise during the study period or planning to join a intensive sport event (e.g. marathon or triathlon); * Intention to lose or gain weight; * Working night shifts regularly; * Smoking regularly * Use of soft and/or hard drugs (cannabis included); * Abuse of alcohol (defined as \>14 glasses (women) or \>21 glasses (men) of alcoholic beverages per week); * Being pregnant or lactating or planning to become pregnant; * Inability to understand study information and/or communicate with staff; * Participation in another study that involves an intervention within two months prior to the intervention; * Working or doing a thesis/internship at the division of Human Nutrition \& Health, or the Food, Health \& Consumer Research group of Wageningen Food \& Biobased Research.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wageningen University & Research

    RECRUITING

    Wageningen, Gelderland, 6708WG, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.